[
  {
    "ts": null,
    "headline": "Biosimilar medicines: the intersection of access, affordability, and innovation",
    "summary": "Since 2006, the advent of biosimilar competition in Europe has played an essential and growing role in catalysing patient access to key biological medicines while achieving significant relief for...",
    "url": "https://finnhub.io/api/news?id=080cfcad4700f3b56e8fabb949b6400583b9779273ce243671f7f983c40c0078",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738301466,
      "headline": "Biosimilar medicines: the intersection of access, affordability, and innovation",
      "id": 132503675,
      "image": "",
      "related": "IQV",
      "source": "Finnhub",
      "summary": "Since 2006, the advent of biosimilar competition in Europe has played an essential and growing role in catalysing patient access to key biological medicines while achieving significant relief for...",
      "url": "https://finnhub.io/api/news?id=080cfcad4700f3b56e8fabb949b6400583b9779273ce243671f7f983c40c0078"
    }
  }
]